The inflammatory profile of chronic kidney disease patients
- 20 December 2021
- journal article
- Published by Heighten Science Publications Corporation in Journal of Clinical Nephrology
- Vol. 5 (3), 107-111
- https://doi.org/10.29328/journal.jcn.1001083
Abstract
Background: Chronic kidney disease is a worldwide public health issue which is associated with an increased risk of end-stage renal failure and cardiovascular disease. Systemic inflammation exists during chronic renal failure. Recent researches have highlighted the pivotal role of inflammation between renal and cardiovascular disease. The aim of our study is to determine the inflammatory profile of the patient suffering from chronic kidney disease and the influence of hemodialysis on this profile. Methods: We carried out a cross sectional study on 93 patients in the Nephrology Department at Hedi Chaker University Hospital, Sfax, South of Tunisia. Among those patients, 72 patients underwent hemodialysis and 21 patients had chronic kidney disease at stage 3. Clinical data and antecedents were collected. Biological samples were taken after informing the patients and taking their consent. Biological data consisted in lipid profile, albumin rate, hemoglobin rate, uric acid concentration and the usual markers of inflammation noting sedimentation rate, C - reactive protein and orosomucoid. Results: Hemodialysis group of the 72 patients had mean hemodialysis vintage of 54.6 ± 43 months. The inflammatory profile was worse in hemodialysis patients compared to chronic kidney disease patients. Both sedimentation rate, C - reactive protein and orosomucoid were higher in hemodialysis group than in chronic kidney disease group with 71 ± 35.3 mm vs. 42.1 ± 15.5 mm (p < 0.05); 14.6 ± 28.7 mg/l vs. 6.7 ± 8 mg/l (p = 0.02); 1.3 ± 0.7g/l vs. 0.9 ± 0.4 g/l (p = 0.01), respectively. Conclusion: Inflammation increases in dialysis patient. It deserves the nephrologist’s consideration in order to minimize its harmful effects. The monitoring of inflammation markers must be integrated into the nephrologist’s medical practice.Keywords
This publication has 14 references indexed in Scilit:
- High Levels of Soluble Tumor Necrosis Factor Receptors 1 and 2 and Their Association with Mortality in Patients Undergoing HemodialysisCardiorenal Medicine, 2015
- Vascular Access Type, Inflammatory Markers, and Mortality in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) StudyAmerican Journal of Kidney Diseases, 2014
- Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study.BMC Nephrology, 2014
- Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysisNephrology Dialysis Transplantation, 2013
- Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokinesWorld Journal of Nephrology, 2013
- Inflammation from dialysis, can it be removed?Nephrology Dialysis Transplantation, 2012
- Biomarkers of Chronic Inflammatory State in Uremia and Cardiovascular DiseaseInternational Journal of Inflammation, 2012
- Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trialNephrology Dialysis Transplantation, 2011
- C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- Dose de dialyse, nutrition, inflammation : quelle est la relation ?Nephrologie & Therapeutique, 2010